Keyphrases
Mantle Cell Lymphoma
100%
Lymphoma
25%
Overexpression
12%
Recurrent mutation
12%
Ibrutinib
12%
Chemotherapy Resistance
12%
Standard of Care
12%
Sequence Method
12%
FDA-approved Drugs
12%
Chromosomal Translocation
12%
Genome Sequencing
12%
Curative Treatment
12%
Novel Agents
12%
Lenalidomide
12%
New Treatment Options
12%
Novel Therapeutic Targets
12%
Cyclin D1 (CCND1)
12%
Aggressive B-cell non-Hodgkin Lymphoma
12%
Medicine and Dentistry
Mantle Cell Lymphoma
100%
B Cell
12%
Ibrutinib
12%
Non-Hodgkin Lymphoma
12%
Lenalidomide
12%
Genome Sequencing
12%
Cyclin D1
12%
Chromosome Translocation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Mantle Cell Lymphoma
100%
Ibrutinib
12%
Nonhodgkin Lymphoma
12%
Lenalidomide
12%
Cyclin D1
12%
Chromosome Translocation
12%